小儿患者静脉血栓栓塞症的治疗
Treatment of Venous Thromboembolism in Pediatric Patients.
作者信息
Malec Lynn, Young Guy
机构信息
BloodCenter of Wisconsin, Milwaukee, WI, USA; Medical College of Wisconsin, Milwaukee, WI, USA.
Department of Pediatrics, Division of Hematology, Children's Hospital of Los Angeles , Los Angeles, CA , USA.
出版信息
Front Pediatr. 2017 Feb 28;5:26. doi: 10.3389/fped.2017.00026. eCollection 2017.
Abstract
Given the increased incidence of venous thromboembolism (VTE) in pediatric patients, which has been associated with increased survival of medically complex patients and increased use of invasive supportive measures, it is important to understand treatment options and unique aspects of anticoagulant use in children. The objective of this mini-review is to outline the goals of treatment, treatment options, and adverse events associated with the use of anticoagulants in pediatric patients with VTE.
摘要
鉴于儿科患者静脉血栓栓塞症（VTE）的发病率增加，这与病情复杂患者的生存率提高以及侵入性支持措施的使用增加有关，了解儿童的治疗选择和抗凝剂使用的独特方面非常重要。本小型综述的目的是概述VTE儿科患者使用抗凝剂的治疗目标、治疗选择和不良事件。
相似文献
1
Treatment of Venous Thromboembolism in Pediatric Patients.
Front Pediatr. 2017 Feb 28;5:26. doi: 10.3389/fped.2017.00026. eCollection 2017.
2
Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials.
Expert Rev Hematol. 2018 Jan;11(1):37-44. doi: 10.1080/17474086.2018.1407241. Epub 2017 Dec 17.
3
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
BMJ. 2019 Jul 24;366:l4363. doi: 10.1136/bmj.l4363.
4
Venous thromboembolism in pediatric trauma patients: Ten-year experience and long-term follow-up in a tertiary care center.
Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26415. Epub 2017 Jan 9.
5
Pediatric venous thromboembolism in relation to adults.
J Vasc Surg. 2012 Jun;55(6):1785-93. doi: 10.1016/j.jvs.2011.07.047. Epub 2011 Sep 23.
6
Risk factors for venous thromboembolism in children.
Int Angiol. 2004 Sep;23(3):195-205.
7
Venous thromboembolism prophylaxis in medically ill patients: a mixed treatment comparison meta-analysis.
J Thromb Thrombolysis. 2018 Jan;45(1):36-47. doi: 10.1007/s11239-017-1562-5.
8
Increasing Incidence and Recurrence Rate of Venous Thromboembolism in Paediatric Oncology Patients in One Single Centre Over 25 Years.
Thromb Haemost. 2017 Nov;117(11):2156-2162. doi: 10.1160/TH17-02-0109. Epub 2017 Nov 30.
9
Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.
Clin Ther. 2014 Oct 1;36(10):1454-64.e3. doi: 10.1016/j.clinthera.2014.06.033. Epub 2014 Aug 3.
10
Pediatric Hospital Acquired Venous Thromboembolism.
Front Pediatr. 2017 Sep 19;5:198. doi: 10.3389/fped.2017.00198. eCollection 2017.
引用本文的文献
1
Comparison of Time Within Therapeutic Range Using Anti-Factor Xa Versus Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin in Children.
J Pediatr Pharmacol Ther. 2023;28(3):228-234. doi: 10.5863/1551-6776-28.3.228. Epub 2023 Jun 2.
2
Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran.
Front Pediatr. 2022 Oct 13;10:1005098. doi: 10.3389/fped.2022.1005098. eCollection 2022.
3
Case Report: Splanchnic Vein Thrombosis as a Complication of Necrotizing Acute Pancreatitis in a Pediatric Patient.
Front Surg. 2022 Apr 1;9:747671. doi: 10.3389/fsurg.2022.747671. eCollection 2022.
4
Population Pharmacokinetic Analysis of Dalteparin in Pediatric Patients With Venous Thromboembolism.
J Clin Pharmacol. 2021 Feb;61(2):172-180. doi: 10.1002/jcph.1716. Epub 2020 Aug 21.
5
A New Test for the Detection of Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in the Emergency Room Setting.
Crit Care Explor. 2019 Aug 20;1(8):e0024. doi: 10.1097/CCE.0000000000000024. eCollection 2019 Aug.
6
Mesenteric venous thrombosis as a complication of appendicitis in an adolescent: A case report and literature review.
Medicine (Baltimore). 2019 Nov;98(48):e18002. doi: 10.1097/MD.0000000000018002.
7
Direct Oral Anticoagulants: Novel Approach for the Treatment of Thrombosis in Pediatric Patients?
Pediatr Cardiol. 2019 Oct;40(7):1431-1438. doi: 10.1007/s00246-019-02159-3. Epub 2019 Jul 20.
8
Venous thromboembolism risk factors in a pediatric trauma population.
Pediatr Surg Int. 2019 Apr;35(4):487-493. doi: 10.1007/s00383-018-4418-y. Epub 2018 Nov 19.
9
Intramural Bowel Hematoma Presenting as Small Bowel Obstruction in a Patient on Low-Molecular-Weight Heparin.
Case Rep Pediatr. 2018 Jun 13;2018:8780121. doi: 10.1155/2018/8780121. eCollection 2018.
10
Sepsis in a Child with Deep Venous Thrombosis - A Case Report.
J Crit Care Med (Targu Mures). 2018 Feb 9;4(1):29-33. doi: 10.1515/jccm-2018-0004. eCollection 2018 Jan.
本文引用的文献
1
Effects of Long-Term Low-Molecular-Weight Heparin on Fractures and Bone Density in Non-Pregnant Adults: A Systematic Review With Meta-Analysis.
J Gen Intern Med. 2016 Aug;31(8):947-57. doi: 10.1007/s11606-016-3603-8. Epub 2016 Feb 19.
2
UNBLOCK: an open-label, dose-finding, pharmacokinetic and safety study of bivalirudin in children with deep vein thrombosis.
J Thromb Haemost. 2015 Sep;13(9):1615-22. doi: 10.1111/jth.13057. Epub 2015 Aug 6.
3
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings.
J Thromb Haemost. 2015 Sep;13(9):1597-605. doi: 10.1111/jth.13038. Epub 2015 Aug 11.
4
Pediatric heparin-induced thrombocytopenia: prevalence, thrombotic risk, and application of the 4Ts scoring system.
J Pediatr. 2015 Jan;166(1):144-50. doi: 10.1016/j.jpeds.2014.09.017. Epub 2014 Oct 14.
5
Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest. 2012 Feb;141(2 Suppl):e737S-e801S. doi: 10.1378/chest.11-2308.
6
Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007.
Pediatrics. 2009 Oct;124(4):1001-8. doi: 10.1542/peds.2009-0768. Epub 2009 Sep 7.
7
Evaluation of enoxaparin dosing requirements in infants and children. Better dosing to achieve therapeutic levels.
Thromb Haemost. 2009 Jan;101(1):86-92.
8
In vivo age dependency of unfractionated heparin in infants and children.
Thromb Res. 2009 Mar;123(5):710-4. doi: 10.1016/j.thromres.2008.07.009. Epub 2008 Sep 30.
9
Enoxaparin for neonatal thrombosis: a call for a higher dose for neonates.
Thromb Res. 2008;122(6):826-30. doi: 10.1016/j.thromres.2007.11.009. Epub 2008 Jan 18.
10
Developmental haemostasis. Impact for clinical haemostasis laboratories.
Thromb Haemost. 2006 Feb;95(2):362-72. doi: 10.1160/TH05-01-0047.
Zotero 插件